Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Forum of Clinical Oncology
Volume 5 (2014): Numero 2 (December 2014)
Accesso libero
Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration
Lindsay A. Renfro
Lindsay A. Renfro
,
Axel M. Grothey
Axel M. Grothey
,
James Paul
James Paul
,
Irene Floriani
Irene Floriani
,
Franck Bonnetain
Franck Bonnetain
,
Donna Niedzwiecki
Donna Niedzwiecki
,
Takeharu Yamanaka
Takeharu Yamanaka
,
Ioannis Souglakos
Ioannis Souglakos
,
Greg Yothers
Greg Yothers
e
Daniel J. Sargent
Daniel J. Sargent
| 10 dic 2014
Forum of Clinical Oncology
Volume 5 (2014): Numero 2 (December 2014)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
10 dic 2014
Pagine:
1 - 7
DOI:
https://doi.org/10.2478/fco-2014-0006
Parole chiave
Colon cancer
,
Adjuvant therapy
,
Meta-analysis
,
Duration of therapy
© 2014 Lindsay A. Renfro et. al.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Lindsay A. Renfro
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Axel M. Grothey
Department of Oncology, Mayo Clinic, Rochester, MN, USA
James Paul
Cancer Research UK, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland
Irene Floriani
Department of Oncology, IRCCS Instituto di RicercheFarmacologiche Mario Negri, Milan, Italy
Franck Bonnetain
Methodological and Quality of Life Unit in Oncology, University Hospital, Besançon, France
Donna Niedzwiecki
Department of Biostatistics, Duke University, Durham, NC, USA
Takeharu Yamanaka
Department of Biostatistics, National Cancer Center, Tokyo, Japan
Ioannis Souglakos
Division of Internal Medicine, University of Crete, Crete, Greece
Greg Yothers
National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Pittsburgh, PA, USA
Daniel J. Sargent
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA